CME Group (NASDAQ:CME) Given New $206.00 Price Target at JPMorgan Chase & Co.

CME Group (NASDAQ:CME) had its price objective boosted by JPMorgan Chase & Co. from $198.00 to $206.00 in a report published on Thursday, Benzinga reports. The brokerage currently has a neutral rating on the financial services provider’s stock.

Other equities analysts have also issued research reports about the stock. Bank of America raised their price objective on shares of CME Group from $209.00 to $216.00 and gave the company a neutral rating in a research report on Thursday. The Goldman Sachs Group lowered shares of CME Group from a neutral rating to a sell rating and set a $195.00 price objective on the stock. in a research report on Wednesday, January 3rd. Barclays raised their price objective on shares of CME Group from $225.00 to $226.00 and gave the company an equal weight rating in a research report on Monday, April 8th. Keefe, Bruyette & Woods lifted their price target on shares of CME Group from $222.00 to $226.00 and gave the company a market perform rating in a research report on Thursday. Finally, Deutsche Bank Aktiengesellschaft reissued a hold rating and issued a $210.00 price target (down previously from $235.00) on shares of CME Group in a research report on Friday, April 5th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of Hold and an average price target of $217.80.

CME Group Price Performance

NASDAQ CME opened at $212.54 on Thursday. The company has a 50 day simple moving average of $214.76 and a 200-day simple moving average of $211.93. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The firm has a market capitalization of $76.51 billion, a price-to-earnings ratio of 24.18, a price-to-earnings-growth ratio of 5.97 and a beta of 0.49. CME Group has a 52-week low of $175.73 and a 52-week high of $223.80.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.44 by $0.06. The business had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.48 billion. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The firm’s revenue was up 3.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.42 earnings per share. Equities research analysts predict that CME Group will post 9.58 earnings per share for the current fiscal year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Stockholders of record on Friday, March 8th were paid a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.16%. The ex-dividend date was Thursday, March 7th. This is an increase from CME Group’s previous quarterly dividend of $1.10. CME Group’s payout ratio is currently 52.33%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in CME. Norges Bank bought a new position in shares of CME Group in the fourth quarter valued at about $959,260,000. Capital Wealth Planning LLC bought a new position in shares of CME Group in the fourth quarter valued at about $253,563,000. Capital World Investors raised its holdings in shares of CME Group by 8.7% in the fourth quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after buying an additional 1,172,575 shares during the last quarter. Morgan Stanley raised its holdings in shares of CME Group by 31.5% in the third quarter. Morgan Stanley now owns 4,858,967 shares of the financial services provider’s stock valued at $972,863,000 after buying an additional 1,163,103 shares during the last quarter. Finally, AEGON ASSET MANAGEMENT UK Plc bought a new position in shares of CME Group in the fourth quarter valued at about $113,772,000. 87.75% of the stock is owned by institutional investors.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.